Clinical Trial Update: Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing Irinotecan plus Cisplatin with Etoposide plus Cisplatin for extensive-stage small cell lung cancer; status is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Small Cell Lung Cancer | Phase 4 | Status: UNKNOWN